"Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 5 (XM26)(Non-Sterile) - Taiwan Registration d10a0760495768352d6a8db22da948e8
Access comprehensive regulatory information for "Leica" Bond Ready-to-Use Primary Antibody Cytokeratin 5 (XM26)(Non-Sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number d10a0760495768352d6a8db22da948e8 and manufactured by LEICA BIOSYSTEMS NEWCASTLE LTD.. The authorized representative in Taiwan is BECKMAN COULTER TAIWAN INC., TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
d10a0760495768352d6a8db22da948e8
Ministry of Health Medical Device Import No. 019851
DHA09401985108
Product Details
Limited to the first level identification range of immunopathological histochemical reagents and kits (B.1860) of the Measures for the Administration of Medical Devices.
B Hematology and pathology devices
B1860 Immunopathological histochemical reagents and kits
Imported from abroad
Dates and Status
Nov 26, 2018
Nov 26, 2028

